These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 11130883

  • 1. CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection.
    Itakura J, Nagayama K, Enomoto N, Sakamoto N, Tazawa J, Izumi N, Marumo F, Sato C.
    J Med Virol; 2001 Jan; 63(1):22-8. PubMed ID: 11130883
    [Abstract] [Full Text] [Related]

  • 2. Variation of hepatitis C virus load, hypervariable region 1 quasispecies and CD81 hepatocyte expression in hepatocellular carcinoma and adjacent non-cancerous liver.
    Young KC, Lin PW, Hsiao WC, Chang TT, Chang YC, Wu HL.
    J Med Virol; 2002 Oct; 68(2):188-96. PubMed ID: 12210407
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of TT virus infection in patients with chronic hepatitis C.
    Zein NN, Arslan M, Li H, Charlton MR, Gross JB, Poterucha JJ, Therneau TM, Kolbert CP, Persing DH.
    Am J Gastroenterol; 1999 Oct; 94(10):3020-7. PubMed ID: 10520863
    [Abstract] [Full Text] [Related]

  • 4. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G, Romano M, Calabrò A, Pedone PV, de Sio I, Persico M, Budillon G, Bruni CB, Riccio A, Zarrilli R.
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [Abstract] [Full Text] [Related]

  • 5. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 6. Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan.
    Tanaka Y, Furuta T, Suzuki S, Orito E, Yeo AE, Hirashima N, Sugauchi F, Ueda R, Mizokami M.
    J Infect Dis; 2003 Jun 01; 187(11):1822-5. PubMed ID: 12751042
    [Abstract] [Full Text] [Related]

  • 7. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T, Tokuda M, Yoshida S, Nakai S, Morishita A, Uchida N, Funaki T, Kita Y, Funakoshi F, Nonomura T, Himoto T, Deguchi A, Kimura Y, Izuishi K, Wakabayashi H, Usuki H, Yoshiji H, Watanabe S, Kurokohchi K, Kuriyama S.
    Int J Oncol; 2005 Mar 01; 26(3):661-71. PubMed ID: 15703821
    [Abstract] [Full Text] [Related]

  • 8. Reactivity to B cell epitopes within hepatitis C virus core protein and hepatocellular carcinoma.
    Pirisi M, Fabris C, Toniutto P, Vitulli D, Soardo G, Falleti E, Gonano F, Ferroni P, Gasparini V, Bartoli E.
    Cancer Res; 1995 Jan 01; 55(1):111-4. PubMed ID: 7528637
    [Abstract] [Full Text] [Related]

  • 9. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F, Vangieri B, Cecere A, Gattoni A.
    Clin Ter; 2004 May 01; 155(5):187-99. PubMed ID: 15344567
    [Abstract] [Full Text] [Related]

  • 10. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.
    Tokita H, Murai S, Kamitsukasa H, Yagura M, Harada H, Takahashi M, Okamoto H.
    J Med Virol; 2002 Aug 01; 67(4):501-9. PubMed ID: 12115995
    [Abstract] [Full Text] [Related]

  • 11. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
    Sonzogni L, Silvestri L, De Silvestri A, Gritti C, Foti L, Zavaglia C, Bottelli R, Mondelli MU, Civardi E, Silini EM.
    Hepatology; 2002 Jul 01; 36(1):195-201. PubMed ID: 12085365
    [Abstract] [Full Text] [Related]

  • 12. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.
    Kato N, Ji G, Wang Y, Baba M, Hoshida Y, Otsuka M, Taniguchi H, Moriyama M, Dharel N, Goto T, Shao RX, Matsuura T, Ishii K, Shiina S, Kawabe T, Muramatsu M, Omata M.
    Hepatology; 2005 Oct 01; 42(4):846-53. PubMed ID: 16175604
    [Abstract] [Full Text] [Related]

  • 13. Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein: correlation with treatment response in hepatitis C virus-infected patients.
    Hofmann WP, Sarrazin C, Kronenberger B, Schönberger B, Bruch K, Zeuzem S.
    J Infect Dis; 2003 Mar 15; 187(6):982-7. PubMed ID: 12660945
    [Abstract] [Full Text] [Related]

  • 14. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK.
    J Gastroenterol Hepatol; 2007 Jul 15; 22(7):1104-11. PubMed ID: 17559381
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.
    Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, Goto T, Moriyama M, Otsuka M, Shiina S, Shiratori Y, Ito Y, Omata M.
    Hepatology; 2003 Jan 15; 37(1):65-71. PubMed ID: 12500190
    [Abstract] [Full Text] [Related]

  • 16. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
    Charni F, Sutton A, Rufat P, Laguillier C, Mansouri A, Moreau R, Ganne-Carrié N, Trinchet JC, Beaugrand M, Charnaux N, Nahon P.
    Cancer Epidemiol Biomarkers Prev; 2011 Jul 15; 20(7):1439-46. PubMed ID: 21610221
    [Abstract] [Full Text] [Related]

  • 17. Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection.
    Bouzgarrou N, Hassen E, Schvoerer E, Stoll-Keller F, Bahri O, Gabbouj S, Cheikh I, Maamouri N, Mammi N, Saffar H, Trabelsi A, Triki H, Chouchane L.
    J Med Virol; 2008 Apr 15; 80(4):607-14. PubMed ID: 18297714
    [Abstract] [Full Text] [Related]

  • 18. Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.
    De Mitri MS, Cassini R, Morsica G, Bagaglio S, Andreone P, Loggi E, Muratori P, Bernardi M.
    J Viral Hepat; 2006 Sep 15; 13(9):574-81. PubMed ID: 16907843
    [Abstract] [Full Text] [Related]

  • 19. Mutations in the putative HCV-E2 CD81 binding regions and correlation with cell surface CD81 expression.
    Kronenberger B, Sarrazin C, Hofmann WP, von Wagner M, Herrmann E, Welsch C, Elez R, Rüster B, Piiper A, Zeuzem S.
    J Viral Hepat; 2004 Jul 15; 11(4):310-8. PubMed ID: 15230853
    [Abstract] [Full Text] [Related]

  • 20. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Abbas E, Shaker O, Abd El Aziz G, Ramadan H, Esmat G.
    Eur J Gastroenterol Hepatol; 2012 Apr 15; 24(4):458-63. PubMed ID: 22293333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.